Sage Journals: Discover world-class research

Open access

Research article

First published 2016-11

Prevalence,Costs and Consequences of “Manovra AIFA” for ICS-LABA Treatment in Patients with Asthma or COPD: A Real-Practice Analysis

Alessandra Bettiol, Jenny Bolcato, Roberta Pirolo [...]

Global & Regional Health Technology Assessment: Italian;Northern Europe and Spanish

Free access

Other

First published 2009-04

Clinical and pharmacoeconomic profile of COPD patients with FEV1 50—60% predicted: pilot study on the impact of the extended indication of ICS/LABA

Roberto Walter Dal Negro, Luca Bonadiman, Claudio Turati [...]

Therapeutic Advances in Respiratory Disease

Free access

Research article

First published 2011-4

The impact of LABA+ICS fixed combinations on morbidity and economic burden of COPD in Italy: a six-year observational study

Roberto Dal Negro, Luca Bonadiman, Silvia Tognella [...]

Therapeutic Advances in Respiratory Disease

Open access

Review article

First published 2009

Management of Asthma with ICS and LABAs: Different treatment strategies

M Van Den Berge, NHT Ten Hacken, HAM Kerstjens [...]

Clinical Medicine Insights: Therapeutics

Open access

Research article

First published 2020

Efficacy and safety of revefenacin for nebulization in patients with chronic obstructive pulmonary disease taking concomitant ICS/LABA or LABA: subgroup analysis from phase III trials

Sanjay Sethi, James F. Donohue, Gary T. Ferguson [...]

Therapeutic Advances in Respiratory Disease

Open access

Research article

First published 2024

Comparative effectiveness and safety of escalating to triple therapy versus switching to dual bronchodilators after discontinuing LABA/ICS in patients with COPD: a retrospective cohort study

Li-Wei Wu, Tzu-Chieh Lin, Tzu-Han Lin [...]

Therapeutic Advances in Respiratory Disease

Retricted access

Review article

First published 2017-8

Role of Long-Acting Muscarinic Antagonist/Long-Acting β 2 -Agonist Therapy in Chronic Obstructive Pulmonary Disease

Sarah E. Petite

Annals of Pharmacotherapy

Free access

Review article

First published 2013-12

Safety of long-acting beta agonists and inhaled corticosteroids in children and adolescents with asthma

Ying Xia, Christina M. L. Kelton, Liang Xue [...]

Therapeutic Advances in Drug Safety

Retricted access

Research article

First published 2017-11

Risk of Cardiovascular and Cerebrovascular Events in COPD Patients Treated With Long-Acting β 2 -Agonist Combined With a Long-Acting Muscarinic or Inhaled Corticosteroid

Jennifer C. Samp, Min J. Joo, Glen T. Schumock [...]

Annals of Pharmacotherapy

Retricted access

Case report

First published 2010-4

Effects of Inhaled Corticosteroids in Monotherapy or Combined with Long-Acting β2-Agonists on Mortality among Patients with Chronic Obstructive Pulmonary Disease

Marie-Christyne Cyr, Marie-France Beauchesne, Catherine Lemière [...]

Annals of Pharmacotherapy

Search results